tiprankstipranks
Advertisement
Advertisement
Standard BioTools Regains Nasdaq Minimum Bid Compliance Status
PremiumCompany AnnouncementsStandard BioTools Regains Nasdaq Minimum Bid Compliance Status
1M ago
Standard BioTools Grants RSUs to Chief Business Officer
Premium
Company Announcements
Standard BioTools Grants RSUs to Chief Business Officer
2M ago
Standard BioTools Adopts New Executive Severance Protection Plans
Premium
Company Announcements
Standard BioTools Adopts New Executive Severance Protection Plans
2M ago
Standard BioTools: Neutral Stance Amid Revenue Contraction Risk and M&A-Dependent Growth Outlook
PremiumRatingsStandard BioTools: Neutral Stance Amid Revenue Contraction Risk and M&A-Dependent Growth Outlook
5M ago
Standard BioTools Details SomaLogic Sale and Profitability Path
Premium
Company Announcements
Standard BioTools Details SomaLogic Sale and Profitability Path
5M ago
Standard BioTools reports Q4 EPS 5c vs (9c) last year
Premium
The Fly
Standard BioTools reports Q4 EPS 5c vs (9c) last year
5M ago
Standard BioTools sees Q4 revenue from cont. ops. $24M, consensus $18.5M
PremiumThe FlyStandard BioTools sees Q4 revenue from cont. ops. $24M, consensus $18.5M
6M ago
Standard BioTools price target lowered to $1.35 from $1.55 at TD Cowen
Premium
The Fly
Standard BioTools price target lowered to $1.35 from $1.55 at TD Cowen
9M ago
Standard BioTools Inc. Reports Q3 2025 Financial Results
Premium
Company Announcements
Standard BioTools Inc. Reports Q3 2025 Financial Results
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100